Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

MGI RIDES U.S. BIO'S COATTAILS

Dec. 6, 1991

AMGEN WINS RULING IN EPO DISPUTE

Dec. 6, 1991

ENZO TEST DETECTS AIDS DIRECTLY

Dec. 5, 1991

U.S. BIO STOCK STAYS HOT

Dec. 5, 1991

PANEL OKS FIELD STUDY GUIDELINES

Dec. 5, 1991

COURT DENIES REQUEST TO BLOCK NICODERM

Dec. 5, 1991

NOVA FILES FOR PUBLIC OFFERING

Dec. 5, 1991

Bt SHOWS PROMISE AGAINST LAWN PESTS

Dec. 5, 1991

APPLIED MICRO LICENSES CONSEPT

Dec. 5, 1991

U.K. APPROVES VESTAR'S ANTI-FUNGAL

Dec. 5, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.